Author:
Kita Tamotsu,Yokoyama Kunihiko,Kinuya Seigo,Taki Junichi,Michigishi Takatoshi,Tonami Norihisa
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine
Reference20 articles.
1. Glinoer D, Hesch D, Lagasse R, Laurberg P. The management of hyperthyroidism due to Graves’ disease in Europe in 1986: results of an international survey.Acta Endocrinol 1987; 185 (Suppl):9–37.
2. Nagayama Y, Izumi M, Nagataki S. The management of hyperthyroidism due to Graves’ disease in Japan in 1988.Endocrinol Jpn 1989; 36:299–314.
3. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves’ disease.J Clin Endocrinol Metab 1990; 70:1518–1524.
4. Catargi BC, Leprat F, Guyot M, Valli N, Ducassou D, Tabarin A. Optimized radioiodine therapy of Graves’ disease: analysis of the delivered dose and of other possible factors affecting outcome.Eur J Endocrinol 1999; 141:117–121.
5. Nordyke RA, Gilbert FI. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves’ disease.J Nucl Med 1991; 32:411–416.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献